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The BCR is a multiprotein complex expressed 
on the surface of B lymphocytes from where it 
transmits critical signals for their development, 
proliferation, and activation. The BCR consists 
of two Ig heavy chains (HCs) and two light 
chains (LCs), forming the antigen-binding and 
membrane-bound Ig molecule (mIg), and the 
signal transduction unit composed of the mb-1–
encoded Ig and the B29-encoded Ig het-
erodimer (Hombach et al., 1990).
Antigen binding to mIg induces phospho-
rylation of cytoplasmic Ig/ tyrosines by the 
tyrosine kinases Lyn (Kurosaki, 1999) and Syk 
(Rolli et al., 2002). The subsequent recruitment 
of Syk to the BCR results in increased Syk activ-
ity and phosphorylation of the adaptor protein 
SLP65 (Wienands et al., 1998), which binds and 
activates the Bruton’s tyrosine kinase (Btk) and the 
phospholipase C2 (PLC2). PLC2 generates 
inositol 1,4,5-trisphosphate (IP3) and diacylglyc-
erol (DAG). IP3 induces Ca2+ influx (Sugawara 
et al., 1997), and DAG activates the Ras gua-
nine nucleotide exchange factor (GEF) RasGRP3 
(Hashimoto et al., 1998; Oh-hora et al., 2003). 
RasGRP3-activated Ras stimulates the two 
serine/threonine kinase isoforms Raf-1 and 
B-Raf, leading to Mek phosphorylation and, 
finally, extracellular signal-regulated kinase (Erk) 
activation (Gold, 2000; Brummer et al., 2002). Erk 
induces transcription of immediate early genes, 
including c-Fos (Richards et al., 2001; Brummer 
et al., 2002), which together with c-Jun transcribes 
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B cell antigen receptor (BCR) signaling is critical for B cell development and activation. 
Using mass spectrometry, we identified a protein kinase D–interacting substrate of 220 kD 
(Kidins220)/ankyrin repeat–rich membrane-spanning protein (ARMS) as a novel interaction 
partner of resting and stimulated BCR. Upon BCR stimulation, the interaction increases in a 
Src kinase–independent manner. By knocking down Kidins220 in a B cell line and generating 
a conditional B cell–specific Kidins220 knockout (B-KO) mouse strain, we show that Kidins220 
couples the BCR to PLC2, Ca2+, and extracellular signal-regulated kinase (Erk) signaling. 
Consequently, BCR-mediated B cell activation was reduced in vitro and in vivo upon Kidins220 
deletion. Furthermore, B cell development was impaired at stages where pre-BCR or BCR signal-
ing is required. Most strikingly,  light chain–positive B cells were reduced sixfold in the B-KO 
mice, genetically placing Kidins220 in the PLC2 pathway. Thus, our data indicate that 
Kidins220 positively regulates pre-BCR and BCR functioning.
© 2015 Fiala et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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RESULTS
Kidins220 binds to the BCR in unstimulated B cells
To identify novel interaction partners of the resting BCR, we 
purified the IgG2a-BCR from mouse K46 B cells using pro-
tein G–coupled beads and identified bound proteins using 
mass spectrometry. In addition to the BCR subunits 2aHC, 
LC, and Ig, we detected Kidins220 (Fig. 1 A). Next, we 
tested whether Kidins220 interacts with other BCR isotypes. 
To this end, we made use of different transfectants of the J558L 
B cell line expressing nitrophenol (NP)-specific IgD-, IgM-, 
or IgG2a-BCRs (Hombach et al., 1988; Schamel and Reth, 
2000). After lysis, BCRs were purified using NP-coupled Seph-
arose beads, and the copurified proteins were analyzed by 
SDS-PAGE and Western blotting (WB); lysates served as con-
trols (CTRLs; Fig. 1 B). We detected association of Kidins220 
with the IgD-, IgM-, and IgG2a-BCR. When J558L cells not 
expressing any BCR were used, Kidins220 was not detected. 
Kidins220 was bound to BCRs on the B cell surface (not de-
picted) and was associated with the BCR in primary splenic 
B cells from B1-8/IEKT mice expressing an NP-specific BCR 
(Fig. 1 C). The Ig and Ig subunits of the BCR are dispens-
able for BCR’s association with Kidins220 because in their 
absence the transmembrane form of mIgD also interacted with 
Kidins220 (not depicted). Furthermore, the Kidins220–BCR 
interaction was specific because Kidins220 was not immuno-
purified with MHC class I (MHCI) from B cells before (Fig. 1 D) 
and after anti-MHC or anti-BCR stimulation (not depicted).
Next, we asked whether BCR triggering changes the con-
stitutive association of Kidins220 with the BCR. K46 cells 
expressing either NP-specific (containing the LC) IgD- or 
IgM-BCRs were stimulated with anti-LC antibodies (Fig. 1 E). 
NP purification of the BCRs demonstrated that the amount 
of Kidins220 purified with the BCR was increased upon stimu-
lation. K46 cells not expressing an NP-specific BCR served as 
negative CTRL. Phosphorylation of Akt indicated that the 
cells were successfully stimulated.
To test whether the increased association of Kidins220 with 
the BCR relied on intracellular signaling, we used the Src ki-
nase inhibitor PP2 (Hanke et al., 1996) that blocks BCR phos-
phorylation and downstream signaling. Indeed, phosphorylation 
of Erk was inhibited by PP2 pretreatment (Fig. 1 F). In contrast, 
PP2 did not abolish the enhanced association of Kidins220 to 
the IgM- or IgD-BCR upon anti-LC stimulation. Treatment 
of the cells with the phosphatase inhibitor pervanadate, which 
induces BCR phosphorylation and downstream signaling 
(Campbell et al., 1995; Wienands et al., 1996), did not enhance 
the Kidins220–BCR interaction (Fig. 1 F). Thus, BCR- 
induced downstream signaling might not be involved in the 
increased association of the BCR with Kidins220 upon trig-
gering. In conclusion, Kidins220 is a novel interaction partner 
of the IgD-, IgM-, and IgG2a-BCR isotypes (Fig. 1 G).
Kidins220 regulates signal transduction  
by the IgD- and the IgM-BCRs
To analyze its role in B cells, we generated IgD- and IgM-BCR–
expressing K46 cell lines (K46Lm and K46Lm, respectively) 
numerous genes such as CD69 (Castellanos et al., 1997; Minguet 
et al., 2008).
B lymphocytes arise from hematopoietic stem cells, lo-
calized in the fetal liver of the developing embryo and in the 
BM of young and adult mice (Rolink and Melchers, 1991). 
Early B cell precursors depend on IL-7 receptor (IL-7R) sig-
naling (Cumano et al., 1990), but as soon as they express the 
pre-BCR (composed of the HC, the surrogate LC, and 
Ig/), pre-BCR signaling induces proliferation by activat-
ing the Ras–Erk pathway and thereby eliminates dependency 
on IL-7 (Fleming and Paige, 2001; Vettermann et al., 2008; 
Mandal et al., 2009). Indeed, mice with a defective Ras–Erk 
pathway exhibit a block at the early pre–B cell stage, whereas 
constitutively active Ras bypasses this pre-BCR checkpoint in 
the absence of pre-BCR expression (Shaw et al., 1999; Nagaoka 
et al., 2000; Yasuda et al., 2008). Rearrangement of the LC 
genes starts at the  locus and only later continues at the  
locus (Arakawa et al., 1996). In mice, 90–95% of WT B cells 
express the LC and only 5–10% the LC (McGuire and 
Vitetta, 1981). Successful LC rearrangement leads to expres-
sion of the IgM-BCR and entry into the immature stage of 
development, where central tolerance is established by differ-
ent mechanisms, including receptor editing (Nemazee, 2006). 
Then, immature B cells leave the BM and finish maturation 
in the spleen, where they develop from immature, transitional 
cells to mature follicular (FO) and marginal zone (MZ) B cells 
(Loder et al., 1999; Allman et al., 2001; Srivastava et al., 2005). 
B cell maturation, as well as survival in the periphery, requires 
the BCR and the B cell–activating factor receptor (BAFFR; 
Lam et al., 1997; Mackay et al., 1999; Gross et al., 2000; Kraus 
et al., 2004).
The protein kinase D (PKD)–interacting substrate of 
220 kD (Kidins220), also called ankyrin repeat–rich mem-
brane-spanning protein (ARMS), was discovered in neurons 
as a substrate of PKD (Iglesias et al., 2000) and, indepen-
dently, as an interaction partner of the p75 neurotrophin 
receptor (Kong et al., 2001). Kidins220 is a large protein 
of 1,715 amino acids containing four transmembrane seg-
ments and cytoplasmic regions with several interaction motifs. 
Kidins220 binds to several receptors, such as the neurotrophin 
receptors TrkA, TrkB, TrkC, and p75 (Kong et al., 2001; Arévalo 
et al., 2004; Chang et al., 2004), a glutamate receptor (López-
Menéndez et al., 2009), the VEGF receptor (Cesca et al., 
2012), and the TCR (Deswal et al., 2013). The interaction of 
Kidins220 with TrkA increases upon stimulation and cou-
ples TrkA to Erk activation (Arévalo et al., 2004). In T cells, 
Kidins220 is constitutively associated with the TCR and 
couples the TCR to Erk activation, possibly by its inter-
action with Raf-1 and B-Raf (Deswal et al., 2013). Thus, 
Kidins220 is a scaffold protein linking several receptors to down-
stream signals, mainly to the Ras–Erk pathway (Neubrand 
et al., 2012).
Here, we identify Kidins220 as a novel interaction partner 
of the BCR. We analyzed this interaction biochemically and 
studied the relevance of Kidins220 for B cell development 
and activation in vitro and in vivo.
 o
n
 Septem
ber 2, 2015
jem.rupress.org
D
ow
nloaded from
 
Published August 31, 2015
JEM 
Article
 of 6
stimulation led to Raf-1 dephosphorylation at the inhibitory 
residue serine259 (S259; Rodriguez-Viciana et al., 2006) and 
an increase in phosphorylation at S338, which is critical for 
Raf-1 activation (Mason et al., 1999; Brummer et al., 2002; 
Dhillon et al., 2002). In contrast to shScrambled cells, Raf-1 
did not display these dynamic changes in phosphorylation in 
shKidins220 cells. Furthermore, in shScrambled, but not in 
shKidins220 cells, we detected a decreased electrophoretic mo-
bility of Raf-1 and B-Raf upon BCR stimulation, which re-
flects several feed-forward and feedback phosphorylation events 
occurring on both isoforms (Brummer et al., 2003; Dougherty 
et al., 2005). Together, these data indicate that functional coupling 
of the BCR to both Raf kinases is enhanced by Kidins220.
Upon stimulation, Raf proteins activate Mek and Mek phos-
phorylates Erk. Indeed, BCR-induced Mek and Erk phosphory-
lations were reduced in shKidins220 cells (Fig. 2 [E and F] for 
K46Lm and Fig. 3 [B and C] for K46Lm). A similar result was 
obtained when the cells were stimulated with antigen nitro-
iodophenol (NIP)–coupled BSA (not depicted), further sup-
porting that Kidins220 positively regulates the Erk pathway 
in K46 cells. Consequently, induced expression of the Erk tar-
get gene product c-Fos was strongly reduced in the shKidins220 
cells (not depicted). When early signaling events upon BCR 
triggering were studied, phosphorylation of the two kinases 
in which Kidins220 was stably knocked down by four differ-
ent Kidins220-specific shRNAs using lentiviral vectors. The 
shRNA #2 resulted in the strongest reduction in Kidins220 
protein expression and copurification with the BCR (not de-
picted). Hence, the shRNA #2 (shKidins220) and a scram-
bled CTRL shRNA cell line (shScrambled; Fig. 2 A for 
K46Lm and Fig. 3 A for K46Lm) were used for all fur-
ther experiments.
Because BCR expression was not impaired in the 
shKidins220 cells (not depicted), we stimulated the cells and 
studied BCR-induced signaling events. When the BCR was 
triggered, up-regulation of CD69, an early B cell activation 
marker, by K46Lm cells was nearly absent upon Kidins220 
knockdown (Fig. 2 B). Furthermore, the shKidins220 cells 
showed less Ca2+ influx upon BCR stimulation than the CTRL 
cells (Fig. 2 C for K46Lm and Fig. 3 D for K46Lm). Thus, 
Kidins220 is required for optimal BCR-induced activation 
of K46 B cells expressing an IgD- or IgM-BCR.
CD69 up-regulation in B cells is controlled by the Ras–
Erk pathway (Minguet et al., 2005). To test whether Kidins220 
is involved in coupling the BCR to Raf-1 and B-Raf, the 
IgD-BCR on shScrambled and shKidins220 cells was stimu-
lated with the anti-idiotypic antibody Ac146. Raf-1 and B-Raf 
were immunopurified and analyzed by WB (Fig. 2 D). BCR 
Figure . Kidins220 constitutively associ-
ates with different BCR isotypes. (A) IgG2a-
BCR was purified from resting K46 B cells, and 
bound proteins were identified by tandem 
mass spectrometry. (B) BCRs from J558L cells 
expressing the indicated NP-specific BCR 
isotypes were purified using NP-coupled  
Sepharose beads, separated by reducing SDS- 
PAGE, and developed by WB as indicated (n = 4). 
(C) Purified splenic B cells from B1-8/IEKT 
mice expressing a transgenic BCR specific for 
NP (lane 1) and from WT C57BL/6 mice (lane 2) 
were lysed, and proteins were NP purified  
and analyzed as in B (n = 3). (D) Unstimulated 
IgD-BCR–expressing J558Lm/mb1flN cells 
(lanes 1, 2, and 4) and no BCR-expressing 
J558L cells (lane 3) were lysed. MHCI was 
purified with an anti-MHCI antibody and the 
BCR with NP-beads, and a CTRL purification 
using isotype CTRL antibody–coupled beads 
was performed. The corresponding lysates 
demonstrate the same sample input for the 
different purifications (n = 3). (E) K46, K46Lm, 
and K46Lm cells were kept unstimulated () or 
were stimulated at 37°C with 3 µg/ml anti-LC 
antibodies for 3 or 10 min. Proteins were NP 
purified and analyzed as in B. In addition, anti–
phospho-Akt WB was performed using the 
lysates (n = 3). (F) K46Lm cells were treated 
with 20 µM PP2 for 30 min at 37°C where indicated. Then cells were kept unstimulated () or stimulated for 3 min with either 3 µg/ml anti-LC or with 
25 µM pervanadate. Proteins were purified and analyzed as in B, and phospho-Erk was detected in lysates. Lanes 1 and 5 are duplicates. The quantifica-
tion of the band intensities is shown (mean ± SEM, n = 3). Paired two-tailed Student’s t test (ns, P > 0.05). (G) Schematic picture of the BCR–Kidins220 
interaction. The ankyrin repeats, proline-rich stretch, SAM (sterile -motif) domain, KIM (kinesin light chain–interacting motif), and PDZ (PSD-95, Discs-
large, ZO-1)-binding motif are indicated.
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from age-matched WT and KO embryos were injected into 
sublethally irradiated Rag2/c/ mice (Fig. 4 A). 2 mo later, 
the recipient mice were analyzed for B cell reconstitution. We 
detected lymphocytes expressing B220 in the BM of WT and 
Kidins220 KO fetal liver–reconstituted animals (Fig. 4 B). How-
ever, Kidins220 KO fetal liver cells were less efficient in gen-
erating B220+ cells than WT CTRLs. Closer analysis of the 
developmental stages of B220+ cells showed a slight increase of 
Kidins220 KO cells in the pro/pre–B cell compartment, and 
recirculating mature B cells were reduced (not depicted).
The reduced efficiency in generating B cells in the Kidins220 
KO fetal liver–reconstituted mice could be caused by a block 
before B-lineage commitment. To specifically study the role 
of Kidins220 in B cell development, we crossed Kidins220 
floxed (Kidins220fl) mice (Cesca et al., 2011, 2012) to mb1Cre 
(mb1Cre) mice. In mb1Cre mice, the Cre recombinase is ex-
pressed from the mb-1 locus from the pro–B cell stage onwards 
(Hobeika et al., 2006). Successful deletion of both Kidins220 
regulating BCR phosphorylation, Lyn and Syk, was significantly 
reduced in the absence of Kidins220 (Fig. 2 G for K46Lm and 
Fig. 3 E for K46Lm). However, BCR down-modulation from 
the cell surface upon BCR triggering was unaltered in shKi-
dins220 cells (not depicted), demonstrating that the reduced 
Kidins220 levels did not globally impair B cell functioning.
Kidins220 is required for optimal B cell  
development in the BM
As constitutive Kidins220 deficiency (KO or Kidins220/) 
causes embryonic lethality in mice (Cesca et al., 2012), we 
tested the ability of Kidins220-deficient hematopoietic pre-
cursors to develop into the B cell lineage by fetal liver adop-
tive transfer. Fetal liver cells were isolated from embryonic day 
(E) 12–14 embryos generated by mating Kidins220+/ mice. 
Similar proportions and phenotype of hematopoietic precur-
sors were observed in Kidins220 WT and KO fetal liver cells 
(see Fig. 6 A). Subsequently, similar numbers of fetal liver cells 
Figure 2. Kidins220 promotes signaling via the IgD-BCR in the K6 B cell line. (A) The lysates of scrambled shRNA (shScrambled) or Kidins220-
specific shRNA #2 K46Lm cells (shKidins220) were analyzed by WB as indicated (n > 3). (B) Cells as in A were stimulated in triplicates with increasing 
amounts of the anti-idiotypic antibody Ac146 for 6 h. Cells were analyzed by flow cytometry for CD69 expression. Fold induction of the percentage of 
CD69+ cells is given (n = 3). The mean ± SEM is shown. Two-tailed Student’s t test (*, P < 0.05; ***, P < 0.001). (C) Cells as in A were stained with the dye 
Indo-1. The ratio of Ca2+-bound Indo-1 to Ca2+-unbound Indo-1 was measured by flow cytometry. Stimulation was induced after 60 s of the measure-
ment with Ac146 (arrow; n = 3). (D) Cells as in A were stimulated with Ac146 for the indicated time points or left untreated. After cell lysis, anti–Raf-1 
(top three rows) and anti–B-Raf (bottom row) immunoprecipitations were performed and analyzed as indicated (n = 2). (E) Cells were treated as in D, and 
the lysates were analyzed by WB as indicated. (F) A quantification of the phospho-Erk/loading CTRL ratio after normalization is shown for seven indepen-
dently performed experiments as in E. The mean ± SEM is plotted. Paired one-tailed Student’s t test (ns, P > 0.05; **, P < 0.01; ***, P < 0.001). (G) Cells as 
in A were stimulated as indicated, and phosphorylated proteins were purified and analyzed by WB using the phospho-specific antibodies as indicated. 
A quantification is shown (mean ± SEM, n = 3). Paired two-tailed Student’s t test (**, P < 0.01; ***, P < 0.001).
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span of pre–B cells (Arakawa et al., 1996) because the  locus is 
activated first in the large pre–B cell stage and the  locus re-
arranged only in the subsequent developmental stage (Engel et al., 
1999). Hence, to test whether reduced LC expression reflects re-
duced survival, we set up BM cultures supplemented with IL-7. 
BM cells from CTRL and B-KO mice expressed similar levels of 
the IL-7R CD127 and survived and proliferated to a similar ex-
tent (not depicted). In contrast, upon withdrawal of IL-7, B-KO 
cells showed reduced survival of IgMlow cells (Fig. 4 K), many of 
which express the pre-BCR (Rolink et al., 1991; ten Boekel 
et al., 1995; Ray et al., 1998), which was reflected by the relative 
enrichment of IgM+ cells in the culture (not depicted). Because 
pre-BCR signals ensure survival in the absence of IL-7 (Arakawa 
et al., 1996), our data suggest that the reduced life span of pre–B 
cells, and consequently lack of LC expression, is caused by 
defective pre-BCR signaling in the absence of Kindins220.
In summary, Kidins220 deficiency in the B cell lineage re-
sulted in reduced B220+ cells in the BM. The reduction of pre–B 
cells, together with the absence of LC expression, might in-
dicate reduced survival of pre–B cells that can be explained by 
defective pre-BCR signaling.
Kidins220 KO B cells preferentially mature to MZ B cells
Next, we analyzed the B cell compartment in peripheral lym-
phoid organs. The spleens of Rag2/c/ mice reconstituted 
with Kidins220 KO fetal liver cells and of B-KO mice showed 
reduced CD19+ cell numbers (Fig. 5 A and not depicted). To 
exclude the possibility that the B cells in the periphery of the 
B-KO mice were those without deletion, we confirmed the 
absence of Kidins220 WT and floxed alleles in purified splenic 
B cells (not depicted).
alleles was confirmed by PCR, and absence of the Kidins220 
protein in ex vivo IL-7–expanded pro–B cells (not depicted).
The Kidins220fl/mb1+/Cre or Kidins220fl/flmb1+/Cre mice 
(B cell–specific KO [B-KO]) were compared with Kidins220+/fl 
mb1+/Cre or Kidins220+/mb1+/Cre CTRLs (Fig. 4 C) because 
no differences were observed between mice expressing 
Kidins220 from one or two alleles (not depicted). Unexpectedly, 
45% of the B-KO mice died before reaching 14 wk of life 
(not depicted). Those animals were smaller, weaker, and pilo-
erected and presented with a hydrocephalus in some cases. Con-
sequently, only healthy animals with similar body weight were 
used for the following analyses.
B-KO mice showed a mild but significant reduction in 
the relative (Fig. 4 D) and absolute (Fig. 4 E) number of 
B220+ cells in the BM. The pro/pre–B cell compartment was 
percentagewise enlarged (Fig. 4 F) as the result of an increase 
in CD43+ pro–B cells percentagewise (Fig. 4 G) and in total 
numbers. The total number of CD43 pre–B cells was re-
duced (not depicted). Furthermore, the percentage of imma-
ture cells was unchanged (Fig. 4 F). In contrast, the percentages 
of transitional B cells in the BM (emigrants) were signifi-
cantly reduced (Fig. 4 H). Similarly, the proportion and total 
number of mature recirculating B cells in the BM were re-
duced (Fig. 3 F and not depicted).
Kidins220 KO mice possess reduced numbers of + B cells
Strikingly, in all B-KO cell populations in the BM, LC expres-
sion was significantly reduced (73% reduction; Fig. 4, I and J). 
This deficiency became even more evident in the peripheral 
B cell populations (85% reduction in spleen and LNs; Fig. 5, 
F and I). Rearrangement of the  locus requires a longer life 
Figure . Kidins220 promotes signaling via the IgM-BCR in the K6 B cell line. (A) The lysates of scrambled shRNA (shScrambled) or Kidins220-
specific shRNA #2 K46Lm cells (shKidins220) were analyzed by WB as indicated (n > 3). (B) Cells as in A were stimulated with 10 µg/ml Ac146 for the 
indicated time points or left untreated. The lysates were analyzed as in Fig. 2 E (n = 3). (C) Quantification of the experiments shown in B (mean ± SEM). 
(D) Cells as in A were analyzed as in Fig. 2 C. Stimulation was induced after 50 s of the initiation of measurement with Ac146 (arrow; n = 3). (E) Cells as in 
A were treated as in Fig. 2 G, and WB was developed as indicated. A quantification is displayed (mean ± SEM, n = 2–3). Paired two-tailed Student’s t test 
(ns, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
 o
n
 Septem
ber 2, 2015
jem.rupress.org
D
ow
nloaded from
 
Published August 31, 2015
6 of 6 Kidins220 regulates B cell activation | Fiala et al.
CD19+CD93CD21highCD23high; Srivastava et al., 2005) in 
B-KO mice when compared with CTRLs (Fig. 5 D). The lev-
els of expression of the IgM- and the IgD-BCR were similar 
between B cells lacking or expressing Kidins220 when matched 
populations were compared (Fig. 5 E). LC+ B cells were se-
verely reduced in the spleen (Fig. 5 F).
The fraction of B1 B cells in the spleen and in the perito-
neal cavity (PC) was not altered, although the proportion of 
total B cells was significantly reduced; B cells in peripheral 
LNs were significantly decreased percentagewise and in num-
bers (Fig. 5, G and H; and not depicted). In addition, LC-
expressing B cells were severely reduced in the LNs (Fig. 5 I). 
Altogether, deletion of Kidins220 results in a reduction of 
Newly developed immature B cells pass through the tran-
sitional stages in the spleen before differentiating into mature 
B cells by sequential steps regulated by signals from the BCR 
(Rowland et al., 2010b) and through the BAFFR (Rowland 
et al., 2010b). The proportion of transitional B cells (gated as 
CD93+ cells) was reduced between B-KO mice and the CTRLs 
(Fig. 5 B). This phenotype was recapitulated in the fetal liver 
adoptive transfer of Kidins220 KO cells (not depicted). B-KO 
mice showed increased percentages of MZ B cells and MZ 
precursors (MZPs) by 200% and the corresponding reduc-
tion in FO B cells (Fig. 5 C). A closer look at the MZ B cell 
compartment revealed that the increase in MZ B cells was 
accompanied by a higher proportion of MZPs (identified as 
Figure . Early B cell development in the BM. Kidins220 is required for the development of + B cells. (A) Sublethally irradiated Rag/c/ 
mice were reconstituted with equal numbers of WT or Kidins220 KO fetal liver cells. (B) The percentage of B220+ cells in the BM of the reconstituted 
mice was measured by flow cytometry (two experimental repeats, n = 5). (C) The genotypes of CTRL and B cell–specific Kidins220 KO (B-KO) mice are 
depicted. (D) An analysis of the BM of CTRL and B-KO mice using the marker B220 (left) as well as its quantification is shown (right; eight experimen-
tal repeats, n = 10–11). (E) The total number of B220+ cells in the BM is shown (eight experimental repeats, n = 11). (F) B cell development in the BM 
of the CTRL and B-KO mice was analyzed using anti-B220 and anti-IgM antibodies (eight experimental repeats, n = 11). (G) BM cells from CTRL and 
B-KO mice were stained using anti-B220, anti-IgM, and anti-CD43 antibodies to analyze early B cell development (eight experimental repeats, n = 
10–11). (H) BM cells as indicated were stained using anti-B220, anti-IgM, and anti-IgD antibodies to analyze the output of B cells from the BM (seven 
experimental repeats, n = 9). (I) CTRL and B-KO B220+ BM cells were analyzed for HC and LC expression (four experimental repeats, n > 6). (J) Per-
centages of HC+LC+ cells as in I in the B220+ immature and mature gates are shown. (K) BM cells from CTRL and B-KO mice were grown for 7 d  
ex vivo with IL-7. Subsequently, IL-7 was removed (day 0) and the cells cultured for another 4 d. The proportion of living cells was determined by flow 
cytometry according to FSC/SCC and normalized to day 0 (n > 3). In all graphs, the mean or mean ± SEM is plotted. Paired two-tailed Student’s t test 
(ns, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
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the limited number of Kidins220 KO B cells prevented a sound 
statistical analysis (Fig. 6 D). As in the BM, the percentage of 
Kidins220 KO B cells was clearly reduced in the periphery 
(15.5 ± 5.2%; Fig. 6 E). FO B cells lacking Kidins220 expres-
sion were significantly reduced and percentages of MZ B cells 
increased, indicating that the differentiation to MZ B cells is 
favored in the absence of Kidins220 (Fig. 6 F). These data 
strongly support a role for Kidins220 in B cell development.
B cell activation is reduced in splenic B cells  
from Kidins220 B-KO mice
The phenotype of the Kidins220 B-KO mice suggests a reduced 
capacity of the pre-BCR and BCR to generate signals im-
portant for development. To test whether BCR triggering–
induced signaling was impaired in primary B cells, we performed 
B cells in peripheral lymphoid organs. In the spleen, termi-
nal B cell maturation is altered as reflected by a skewed differ-
entiation toward the MZ compartment.
We next investigated whether the B-KO phenotype 
was reproduced under competitive conditions. To this end, 
Rag2/c/ mice were reconstituted with Kidins220/ 
or Kidins220+/ (expressing the CD45.2 marker) and WT 
(expressing the CD45.1 marker) fetal liver cells at a 1:1 cell ratio 
(Fig. 6 A). No differences in percentages or in the expression 
of extracellular markers (CD93, CD34, CD45, and CD19) 
were observed between the fetal liver cells of WT or Kidins220 
KO mice (Fig. 6 A). Kidins220 KO B cells hardly developed 
under competition, constituting 10.9 ± 3.6% of the total B220+ 
cells in the BM and at all maturation stages analyzed (Fig. 6, 
B and C). The proportion of + B cells was reduced; however, 
Figure . B cell development in the periphery. MZ B cells specifically accumulate in the absence of Kidins220. (A) Total numbers of CD19+ cells 
in the spleen of CTRL and B-KO mice (eight experimental repeats, n ≥ 10). (B) The percentage of CD93+ transitional B cells in the spleen was quantified 
(six experimental repeats, n ≥ 10). (C) MZ/MZP and FO B cell development in the spleen was analyzed by flow cytometry (six experimental repeats, n ≥ 
10). (D) Detailed analysis of the MZ B cell population (six experimental repeats, n ≥ 10). (E) The levels of IgM- and IgD-BCR expression in matched 
populations were analyzed by flow cytometry (n ≥ 3). (F) Splenic B cells were analyzed for IgM and LC expression (six experimental repeats, n ≥ 10). 
(G) The percentage of CD19+ B cells (left) and their proportion of CD5+ B1 cells (right) was analyzed in the PC (four experimental repeats, n = 7). (H) In 
the LNs, the percentage of CD19+ B cells was analyzed (six experimental repeats, n ≥ 10). (I) The percentage of B cells expressing the LC was analyzed 
in LNs (six experimental repeats, n ≥ 10). In all graphs, the mean or mean ± SEM is plotted. Paired two-tailed Student’s t test (ns, P > 0.05; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001).
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reduction) in B-KO cells, which might account for the re-
duced Ca2+ influx observed. When B cells obtained from the 
mixed reconstituted mice (Fig. 6 A) were stimulated ex vivo, 
CD86 and CD69 up-regulation was only impaired in those 
cells lacking Kidins220 expression (Fig. 8).
Collectively, these data suggest that Kidins220 is involved 
in initiating BCR signaling and, in particular, in coupling the 
BCR to the Ras–Erk and Ca2+ pathways in primary mature 
B cells, thereby being a positive regulator of B cell activation. In 
contrast, activation of the PI3K pathway and cell survival upon 
BCR triggering might not strongly depend on Kidins220.
B cell immune responses are impaired in Kidins220 B-KO mice
To investigate whether the reduction of + B cells in the B-KO 
mice is physiologically relevant, we immunized CTRL and 
B-KO mice with NP-coupled KLH (NP-KLH). Importantly, 
primary immune responses driven by the hapten NP are 
accounted by BCRs carrying the LC (Reth et al., 1978). 
Kidins220 deletion in B cells reduced the germinal center 
(GC) reaction in the B-KO mice after 6 d of immunization 
(Fig. 9 A). Furthermore, the B-KO mice generated less NP-
specific IgG1 class-switched B cells than the CTRL mice 
(Fig. 9 B) and reduced anti-NP IgM and IgG serum antibody 
titers (Fig. 9 C). These results could be explained by a reduc-
tion in the number of NP-recognizing B cells or by defective 
antigen-induced B cell activation in vivo.
ex vivo stimulations. First, purified splenic B cells from CTRL 
or B-KO mice were stimulated via the BCR using anti- 
IgM Fab2 antibody fragments or via TLR9 using CpG- 
oligodeoxynucleotides. Proliferation was measured by CFSE 
dilution. BCR-induced proliferation was reduced in the B-KO 
cells, whereas survival was not affected (Fig. 7 A and not depicted). 
In contrast, stimulation with CpG resulted in equal levels of 
strong proliferation; also proliferation in response to LPS and 
anti-RP105 was not diminished in B-KO cells (Fig. 7 A and not 
depicted), indicating that signaling from the BCR was specif-
ically affected. BCR expression levels were similar to those of 
WT cells (Fig. 5 E), excluding that lower BCR levels were the 
cause of less BCR signaling in B-KO B cells. Second, purified 
B cells were stimulated with increasing concentrations of anti-
IgM Fab2 and up-regulation of early activation markers was 
quantified by flow cytometry. B-KO cells showed a reduction 
in the BCR-induced expression of CD86 and CD69 (Fig. 7, 
B and C). Third, we measured the activation of intracellular 
signaling cascades upon BCR triggering in CTRL and B-KO 
purified splenic B cells. B-KO cells showed a reduced degree 
of BCR-induced Ca2+ influx (Fig. 7 D). Likewise, the acti-
vation of the Ras–Erk pathway, as measured by anti–phospho-
Mek and anti–phospho-Erk by WB, was reduced (up to 60% 
reduction), and phosphorylation of Akt at its activating site 
S473 was slightly diminished in B-KO cells (Fig. 7 E, 30% re-
duction). Phosphorylation of PLC2 was also reduced (92% 
Figure 6. B cells lacking Kidins220 have 
a competitive disadvantage in BM re-
population. (A) Scheme of the competitive 
repopulation assay. Fetal liver WT cells from 
CD45.1 embryos were mixed with fetal liver 
cells obtained from Kidins220+/ (HET) or 
Kidins220/ (KO) embryos from the same 
litter. The fetal liver cells isolated from em-
bryos on E13.5 were analyzed by flow cy-
tometry for percentages of hematopoietic 
precursors. (B) Mean chimerism in posttrans-
plant competitive recipients transplanted 
with 1:1 ratios of donor (Kidins220+/ [blue] 
or Kidins220/ [red], CD45.2) and competi-
tor cells (Kidins220+/+, CD45.1 [white]) in the 
BM. (C) B cell development in the BM. Repre-
sentative panels and quantifications are 
depicted. (D) Flow cytometry analysis of HC 
and LC expression was performed; repre-
sentative panels are shown. (E) Percentage of 
CD19+ cells in the spleen of the recipient 
mice. (F) Splenic B cell maturation was ana-
lyzed; representative dot plots and the per-
centages of FO and MZ/MZP B cells of mice 
reconstituted with 1:1 WT/Kidins220/ fetal 
liver cells are displayed. In all graphs, the 
mean ± SEM is plotted (n = 6). Two-tailed 
Student’s t test (**, P < 0.01; ***, P < 0.001).
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inducing T-independent type II responses, and (2) TNP-coupled 
KLH, inducing T-dependent responses.
The T-independent TNP-Ficoll immunization revealed 
reduced numbers of ASCs for IgM and IgG (Fig. 9 D) and 
reduced TNP-specific IgM and IgG3 serum titers in B-KO 
mice when compared with CTRLs at day 7 after immuniza-
tion (Fig. 9 E). Likewise, the “early” TNP-KLH immune re-
sponses (namely anti-TNP IgM ASC and anti-TNP IgM serum 
titers) were impaired in B-KO mice when compared with 
CTRLs (Fig. 9, F and G, left). In contrast, in the TNP-KLH 
To distinguish between these two possibilities and because 
B cell activation ex vivo was impaired in the absence of Ki-
dins220, we were prompted to identify an antigen whose rec-
ognition was not based on the presence of the LC. When we 
used the hapten TNP coupled to KLH to immunize CTRL 
mice, we found that 82.4% of the antibody-secreting cells 
(ASCs) present in the spleen secreted + antibodies correlating 
with the proportion of IgM++ cells in the spleen of these mice 
(81.7 ± 1.3%; not depicted). Thus, we performed two immu-
nizations using CTRL and B-KO mice: (1) TNP-coupled Ficoll, 
Figure . Kidins220 promotes signaling via the BCR in primary B cells. (A) CFSE-labeled splenic B cells from CTRL and B-KO mice were stimulated 
with 1 µg/ml anti-IgM Fab2 fragments or 2.5 µg/ml CpG or left untreated (gray shaded). After 3 d the proliferation-induced dilution of the CFSE dye was 
measured by flow cytometry (three experimental repeats, n = 5). (B and C) Cells as in A were stimulated with anti-IgM Fab2 fragments for 11 h and ana-
lyzed by flow cytometry using anti-CD86 (B) and anti-CD69 (C) antibodies. After normalization to the unstimulated cells, the fold induction of the mean 
fluorescent intensity (MFI) is shown (three experimental repeats, n = 5). (D) Ca2+ influx of the cells as in A was measured as in Fig. 2 D. Stimulation was 
induced with 1 µg/ml anti-IgM Fab2 fragments (arrow; two experimental repeats). (E) Cells as in A were stimulated with 3 µg/ml anti-IgM Fab2 frag-
ments for the given time points and lysed, and proteins were separated by SDS-PAGE. Phospho-Mek, phospho-Erk, phospho-Akt, phospho-PLC2, and 
GAPDH were detected by WB (two to three experimental repeats). In all graphs, mean ± SEM is plotted. Paired two-tailed Student’s t test (ns, P > 
0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
Figure . After competitive transfer, Ki-
dins220 promotes primary B cell activation 
ex vivo. (A and B) Splenic B cells from com-
petitive recipient mice transplanted with 1:1 
ratios of fetal liver derived from either Ki-
dins220+/ (HET, CD45.2, blue) and Kidins220+/+ 
(WT, CD45.1, light blue) or Kidins220/ (B-KO, 
CD45.2, red) and Kidins220+/+ (WT, CD45.1, 
light red), as described in Fig. 6 A, were stimu-
lated with anti-IgM Fab2 fragments for 11 h 
and analyzed by flow cytometry using anti-
CD86 (A) and anti-CD69 (B) antibodies. After 
normalization to the unstimulated cells, the 
fold induction of the mean fluorescent inten-
sity (MFI) as mean ± SEM is shown. Paired 
two-tailed Student’s t test (*, P < 0.05;  
**, P < 0.01; ***, P < 0.001; n = 6).
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and (b) clearly demonstrate that T-independent and early 
T-dependent responses are impaired in mice lacking Kidins220 
expression in B cells.
DISCUSSION
In this study, we identified Kidins220 as a novel interaction 
partner of the resting and stimulated BCR and show that it 
immunization the anti-TNP IgG ASC and anti-TNP IgG1 
serum titers were similar to the CTRLs (Fig. 9, F and G). The 
same held true for the GC reaction, measured as GL7+CD95+ 
cells by flow cytometry (not depicted). The percentage of 
plasma cells measured as CD19+CD138+ was decreased in the 
B-KO mice. Altogether, these results (a) support that the ob-
served decrease in + B cells is indeed physiologically relevant 
Figure . Absence of Kidins220 reduces the B cell response in vivo. (A) CTRL and B-KO mice were immunized with NP-KLH (- and T-dependent 
immunization) and analyzed after 6 d. The frequency of splenic GC B cells (CD19+B220+GL7+CD95+) is plotted as mean ± SEM from four to five mice per 
group. (B) Frequency of splenic NP-reactive IgG1-switched B cells of the mice as in A. (C) ELISA of NP-specific IgM (left) and IgG1 (right) in CTRL mice 
immunized only with aluminum hydroxide (Alum) or CTRL and B-KO mice immunized with NP-KLH from the mice shown in A. (D) CTRL and B-KO mice 
were immunized with TNP-Ficoll (-independent, T-independent immunization) and Alum. ELISPOT analysis of splenic TNP-specific IgM-secreting cells 
(left) and TNP-specific IgG-secreting cells (right) at 7 d after immunization. CTRL mice injected only with Alum served as a CTRL. Data of two independent 
experiments were pooled, and the mean ± SEM from six mice per group is shown. (E) ELISA of TNP-specific IgM (left) and IgG3 (right) from the mice 
shown in D. (F) CTRL and B-KO mice were immunized with TNP-KLH (-independent, T-dependent immunization) and Alum. ELISPOT analysis of splenic 
TNP-specific IgM-secreting cells (left) and TNP-specific IgG-secreting cells (right) 7 d after immunization. CTRL mice injected with Alum served as a CTRL. 
Data of two independent experiments were pooled, and the mean ± SEM from four to eight mice per group is plotted. (G) Serum titers of TNP-specific 
IgM (left) and IgG1 (right) from the mice shown in F measured by ELISA. (H) The percentage of CD138+ B cells upon immunization as in F is shown. Two-
tailed Student´s t test (ns, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001).
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is activated upon BCR triggering by direct Nck recruitment 
to the phosphorylated BCR (Castello et al., 2013). It is plau-
sible that low levels of BCR phosphorylation permit activation 
of this pathway. In contrast, a low level of Syk activity might 
not suffice to optimally activate the PLC2–Ca2+ pathway. Our 
ex vivo results are further supported by the impaired activa-
tion of B cells in vivo. We found reduced T cell–independent 
and early T cell–dependent responses upon immunization with 
a non-LC restricted antigen. Altogether, our data show that 
Kidins220 specifically couples the BCR to the Ca2+ and Ras–
Erk pathways and therefore is crucial for optimal BCR-mediated 
cellular activation.
The embryonic lethality of the Kidins220 deficiency pre-
cluded analysis of B cell development. Thus, we used two alter-
native approaches: (1) fetal liver chimeras, as the Kidins220/ 
embryos are unaltered until E14.5 (Cesca et al., 2012), includ-
ing the percentages of hematopoietic and B cell–primed pre-
cursors, and (2) B cell–specific deletion of Kidins220 (named 
B-KO) achieved by breeding Kidins220fl with mb1Cre mice, 
promoting deletion in the pro–B cell stage (Hobeika et al., 2006). 
Mice reconstituted with Kidins220/ fetal liver cells showed 
strongly reduced numbers of B cells in the BM. Furthermore, 
B cells lacking Kidins220 have a competitive disadvantage in 
BM repopulation. However, B cell numbers were only slightly 
reduced in the B-KO mice. This suggests that Kidins220 has 
an important role in development before B cell commitment 
that deserves further investigation.
Despite these quantitative differences, we found that 
Kidins220 is involved in regulating several steps in the develop-
ment of B cells. During B cell development the pre-BCR and 
the BCR transmit signals using the Ras–Erk pathway (Fleming 
and Paige, 2001; Rowland et al., 2010a). Indeed, constitutive 
activation of this pathway mediates survival of pre–B cells 
in vivo (Nagaoka et al., 2000) and rescued reduced levels of 
antigen-independent BCR signaling (Rowland et al., 2010a). 
Our data support a model in which Kidins220 links the pre-
BCR and BCR to the Ras–Erk pathway during development 
and immune responses. Our arguments will follow the step-
wise analysis of B cell development.
First, the absolute number of pro–B cells was unaffected by 
the absence of Kidins220 in B-KO mice. Because survival and 
proliferation of pro–B cells depend on IL-7 (Cumano et al., 
1990), Kidins220 might not play a role in IL-7R signaling.
Second, the number of pre–B cells was reduced. The pre-
BCR activates the Ras–Erk pathway and allows cells to prolifer-
ate in response to IL-7, resulting in a population of cycling large 
pre–B cells (Fleming and Paige, 2001). At this stage, the  locus 
is activated and, in the case of successful rearrangement, cells 
will exit this compartment expressing a LC-containing IgM-
BCR (Engel et al., 1999). B cell proliferation in the presence 
of IL-7 was normal in the absence of Kidins220, and those 
cells that exited the BM expressed a LC-containing BCR. 
Thus, most likely, impaired proliferation of pre–B cells in the 
presence of IL-7 was not responsible for the reduced propor-
tion of these cells in the B-KO mice. In the absence of a suc-
cessfully assembled IgM-BCR, signals from the pre-BCR are 
regulates BCR signaling. Although Kidins220 expression was 
first thought to be restricted to the nervous system (Iglesias 
et al., 2000), expression has now also been demonstrated for 
T (Jean-Mairet et al., 2011; Deswal et al., 2013) and B cells 
(this study).
In neurons, Kidins220 binds to TrkA, and this association 
is increased upon stimulation (Arévalo et al., 2004). Similarly, 
we have observed an enhanced Kidins220–BCR interaction 
upon BCR triggering. However, induction of phosphoryla-
tion by the pan-phosphatase inhibitor pervanadate (Campbell 
et al., 1995; Wienands et al., 1996) did not result in increased 
Kidins220–BCR association. In addition, antibody binding 
to the BCR in the presence of the Src-kinase inhibitor PP2 
(Hanke et al., 1996), which impaired BCR phosphorylation 
and downstream signaling, still enhanced BCR–Kidins220 
interaction. Because ligand binding to the BCR might induce 
structural changes within preformed BCR clusters (Schamel 
and Reth, 2000; Yang and Reth, 2010), we suggest that struc-
tural changes and/or Src-independent signaling promotes fur-
ther association of Kidins220 with the BCR.
Analysis of BCR signaling in the absence of Kidins220 re-
vealed that phosphorylation of Lyn, Syk, and PLC2 was re-
duced and Ca2+ mobilization diminished. Phosphorylation of 
SLP65 by Syk is required for efficient recruitment and activa-
tion of PLC2 and subsequent Ca2+ mobilization (Koretzky 
et al., 2006). Thus, it is plausible that in the absence of Kidins220 
SLP65 is not properly phosphorylated and PLC2 subopti-
mally activated. Additionally, Kidins220 binds to and becomes 
phosphorylated by PKD in neurons (Iglesias et al., 2000). In 
B cells, PKD (formerly known as PKC) interacts with the 
BCR, Syk, and PLC2, and its activation relies on the presence 
of PLC2-produced DAG (Sidorenko et al., 1996). Therefore, 
the BCR–Kidins220 interaction might promote association 
with Syk, PLC2, and PKD, thereby supporting the activation 
of PLC2 and PKD.
Impaired activation of PLC2 reduces Ras–Erk pathway 
activation (Wheeler et al., 2013). Accordingly, in shKidins220 
cells, B-Raf and Raf-1 were poorly activated upon BCR stimu-
lation as estimated by their impaired phosphorylation-dependent 
gel retardation (Brummer et al., 2003; Dougherty et al., 2005). 
In addition, phosphorylation at S338, a critical residue for Raf-1 
activation (Mason et al., 1999; Brummer et al., 2002; Dhillon 
et al., 2002) was hardly detected in the absence of Kidins220. 
These data suggest that functional coupling of the BCR to the 
Raf kinases requires Kidins220. Importantly, phosphorylation of 
Mek, the common substrate of Raf-1 and B-Raf, was strongly 
reduced and accompanied by reduced Erk phosphorylation 
in shKidins220 cells and primary B-KO cells.
Commensurate with impaired Erk activation, induction 
of its target gene products, c-Fos and CD69, was strongly re-
duced in the absence of Kidins220. B-KO cells showed reduced 
cell proliferation upon BCR stimulation, whereas proliferation 
toward the TLR9 ligand CpG was normal. Stimulation of the 
PI3K–Akt pathway upon BCR triggering was only partially 
diminished by the absence of Kidins220, being also in line with 
a similar B cell survival ex vivo. The BCAP–PI3K–Akt pathway 
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develop into MZ B cells (reviewed in Pillai and Cariappa [2009]). 
Indeed, the MZ B cell compartment was also increased in the 
mixed fetal liver–reconstituted mice. However, in those mice 
WT cells compensate for the total output from the BM. Thus, 
we favor a scenario in which reduced BCR signaling results 
in a skewed development toward MZ B cells. This is in line with 
the SLP65 KO mice (Jumaa et al., 1999; Gerlach et al., 2003).
Sixth, it was suggested that the mature B cell pool (B2 or 
FO cells) requires tonic BCR signals for its maintenance (Lam 
et al., 1997; Kraus et al., 2004). We observed reduced numbers 
of mature B cells in the spleens, PC, and LNs of the B-KO 
mice, which might result from the reduced output from the 
BM and suboptimal B cell survival in the periphery. Although 
the last deserves deeper investigation, it might once more link 
Kidins220 to the transmission of BCR signals.
Lastly, T-independent and early T-dependent B cell immune 
responses were reduced in Kidins220 B-KO mice. However, 
late T-dependent responses (switch to IgG isotypes) were simi-
lar to the WT mice, suggesting that T cell help compensates 
for the defective BCR activation. Moreover, BCR internal-
ization and antigen presentation on MHCII were normal in 
cells from the B-KO mice (unpublished data), indicating that 
Kidins220 does not globally regulate B cell functioning.
We did not find experimental evidence for Kidins220 play-
ing a role in signaling downstream of other receptors expressed 
in the B cell linage, such as the BAFFR (unpublished data), 
IL-7R, or TLR9. Hence, our results provide strong evidence 
that Kidins220 specifically regulates pre-BCR and BCR sig-
naling in B cells.
MATERIALS AND METHODS
Cells and mice. The mouse B cell line K46 and its NP-specific mIgD- and 
mIgM-BCR–expressing transfectants K46Lm and K46Lm, respectively, 
were previously described (Kim et al., 1979; Justement et al., 1990). The mouse 
plasmacytoma line J558L and the different NP-specific BCR isotype–expressing 
transfectants J558Lm/mb1flN, J558Lm/mb1flN, and J558L2am/mb1 were 
also described previously (Oi et al., 1983; Hombach et al., 1988; Schamel 
and Reth, 2000). These cells were cultured in RPMI 1640 complete me-
dium supplemented with 10% FCS, 2 mM l-glutamine, 100 U/ml penicillin/
streptomycin, 10 mM Hepes, and 50 mM 2-mercaptoethanol and grown at 
37°C in a humidified atmosphere with 5% CO2. K46 transfectants were grown 
under 1 µg/ml MPA selection supplemented with 1.2 mM xanthine and 
0.11 mM hypoxanthine. Cells expressing shKidins220 or shScrambled were 
selected and maintained with 2.5 µg/ml puromycin.
The B1-8/IEKT, C57BL/6Jax, C57BL/6Rag/c/, C57BL/6-Ly5.1, 
and Kidins220mb1hCre mice were bred under specific pathogen–free condi-
tions. The Kidins220+/ and Kidins220+/fl mice (Cesca et al., 2012) were pro-
vided by G. Schiavo (University College London, London, England, UK). The 
B1-8/IEKT mice (Takeda et al., 1993; Sonoda et al., 1997) and the mb1hCre 
mice (Hobeika et al., 2006) were described previously. All of them were back-
crossed to C57BL/6 for at least 10 generations. Mice were sex and age matched 
with litter CTRLs whenever possible. All animal protocols (G12/64) were per-
formed according to the German animal protection law with permission from 
the Veterinär und Lebensmittelüberwachungsbehörde Freiburg.
Mass spectrometry. The protein G–bead-purified IgG2a-BCR of K46 cells 
(and copurified proteins) were reduced by 1 mM DTT, alkylated using 5.5 mM 
iodoacetamide, and separated by SDS-PAGE. Gel lanes were cut into 10 equal 
slices, samples in-gel digested using trypsin (Promega), and resulting peptides 
processed on STAGE tips as described previously (Sprenger et al., 2013).
then crucial to activate the  locus (Dingjan et al., 2001; Bai et al., 
2007) and to promote survival ensuring a life span long enough 
for LC rearrangement (Arakawa et al., 1996; Derudder et al., 
2009). Importantly, pre–B cells from B-KO mice exhibited re-
duced survival upon withdrawal of IL-7 in vitro, and expression 
of the LC was absent in B cells lacking Kidins220. Similarly, 
mice deficient in Btk or PLC2 have reduced numbers of + 
B cells (Dingjan et al., 2001; Bai et al., 2007), supporting ge-
netically that Kidins220 is part of the Btk/PLC2 signaling 
module leading to activation of the  locus. Altogether, these 
data support a model in which pre-BCR signaling is impaired 
in the absence of Kidins220, leading to a reduced life span of 
pre–B cells and precluding the rearrangement of and expres-
sion from the  locus.
Third and alternatively, reduction of + cells could be caused 
by impaired BCR signals in immature B cells that control cen-
tral tolerance in the BM. Upon IgM-BCR expression, BCR 
specificity will be tested for autoantigen recognition (Grandien 
et al., 1994). In the case of binding to an autoantigen, the BCR 
will transmit signals to initiate receptor editing to ensure that 
the cells expressing an autoreactive receptor do not leave the 
BM (Tiegs et al., 1993). New LC rearrangements might re-
place the autoreactive BCR for an innocuous one (Nemazee, 
2006). Hence, efficient receptor editing leads to an increase in 
the use of LC (Gay et al., 1993). BCR signaling in the ab-
sence of Kidins220 is reduced; thus, the threshold to initiate 
receptor editing might not be reached. An impairment in 
central tolerance would explain the observed reduction of + 
cells and would possibly result in autoantibody production. To 
test this hypothesis, we analyzed serum from Kidins220 KO 
and CTRL mice for antibodies reactive to dsDNA. We did not 
detect enhanced presence of autoantibodies in young B-KO 
mice (unpublished data). The short life span of the B-KO mice 
precludes analysis in older mice that might accumulate autoan-
tibodies. Nevertheless, the reduction of + B cells is physiologi-
cally relevant because B-KO mice cannot mount an effective 
primary anti-NP immune response that is dominated by BCRs 
containing the LC.
Fourth, the differentiation of immature B cells into transi-
tional B cells and their export from the BM depends on BCR-
induced Erk activation (Rowland et al., 2010b). In B-KO mice 
transitional B cell populations in the BM and the spleen were 
significantly reduced, suggesting that suboptimal BCR signal-
ing might preclude efficient B cell export from the BM and 
population of the periphery.
Fifth, we found an increased proportion of MZ B cells and 
their precursors in the spleen. In several animal models reduced 
output of B cells from the BM is accompanied by a propor-
tionally enlarged MZ population (“bottleneck” model; Martin 
and Kearney, 2002). This could be a compensatory mecha-
nism to ensure the maintenance of the quick responding MZ 
“effector” B cells. In an alternative model the signal strength 
from the BCR at the transitional B cell stages defines whether 
the B cell develops into an FO cell (strong strength) or MZ 
B cell (weak strength; Pillai and Cariappa, 2009). A weaker 
BCR signaling strength might prone transitional B cells to 
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previously (Brummer et al., 2002). Phospho-tyrosine immunoprecipitations 
were performed with PT-66 Sepharose (Sigma-Aldrich). Band intensities 
were quantified using the ImageQuant TL software.
B cell purification and Ca2+ flux. Lymphocytes were isolated from the or-
gans, and erythrocytes were removed by incubation in erythrocyte lysis buffer, 
150 mM NH4Cl/10 mM KHCO3, for 2–4 min at room temperature. Un-
touched B cells were purified using the MACS B cell isolation kit (Miltenyi 
Biotech). Purity was >90%, as confirmed by flow cytometry using anti-CD19.
For Ca2+ flux analysis, cells were labeled in the dark with 5 µg/ml Indo-1 
and 0.5 µg/ml Pluronic F-127 (both from Molecular Probes, Life Technologies) 
for 45 min in RPMI containing 1% FCS. Cells were washed and kept on ice in 
RPMI 1% FCS until measurement. The baseline was recorded, and cells were 
stimulated with the indicated antibody. The change of the ratio of Ca2+-bound 
versus Ca2+-unbound Indo-1 was followed for 5 min with an LSRII fluor-
escence spectrometer (BD). Data were analyzed with FlowJo 6.1 software.
Ex vivo experiments and IL-7 BM cultures. For ex vivo experiments, 
cells were kept in RPMI containing 10% FCS, 2 mM l-glutamine, 100 U/ml 
penicillin/streptomycin, 10 mM Hepes, and 50 mM 2-mercaptoethanol at 
37°C in a humidified atmosphere with 5% CO2. For ex vivo activations, puri-
fied B cells (0.106/sample) were incubated with different concentrations of 
anti–IgM Fab2 fragments (Dianova) for 11 h and then stained with PB-labeled 
anti-CD19 (BioLegend), PECy7-labeled anti-CD69 (eBioscience) or PE-
labeled anti-CD69 (eBioscience), and PE-labeled anti-CD86 (BioLegend).
For proliferation experiments, purified B cells (0.2 × 106/sample) were 
labeled with CFSE in PBS containing 0.5% BSA according to the manufac-
turer’s instructions (Invitrogen) for 10 min at 37°C in the dark and 5 min on 
ice. After 3 d in culture with the appropriate stimulus (1 µg/ml anti–IgM 
Fab2 fragments or 2.5 µg/ml CpG [ODN 1668; InvivoGen]) in the presence 
of 0.5 ng/ml IL-4 (PeproTech), cells were stained with PB-labeled anti-
CD19 (BioLegend). CFSE fluorescence of the CD19+ cells was measured by 
flow cytometry.
BM cultures were prepared from freshly isolated BM cells after erythrocyte 
lysis. Cells were cultured in IMDM containing 10% FCS, 100 U/ml penicillin/
streptomycin, 50 mM 2-mercaptoethanol, and IL-7 at 37°C with 7.5% CO2 
for 1 wk. Then the culture was split and grown either with or without IL-7. 
Survival and surface receptor expression were analyzed by flow cytometry.
Fetal liver reconstitution. For the fetal liver reconstitution experiments, 
female Kidins220+/ mice were mated with male Kidins220+/ mice. Embryos 
were taken and fetal liver cells isolated on E12.5, E13.5, or E14.5. Equal num-
bers of Kidins220 KO and WT fetal liver cells were matched for the embry-
onic developmental stage and injected into sublethally (400 rad) irradiated 
Rag// mice. After 2 mo, the animals were killed and analyzed for re-
constitution. For competitive reconstitution experiments, embryos obtained 
from WT CD45.1 mice were used.
Immunization, ELISA, and ELISPOT assay. To immunize mice, 4-
hydroxy-3-NP coupled to KLH (NP28-KLH), 2,4,6-TNP conjugated to 
KLH (TNP20-KLH), and TNP conjugated to AECM-Ficoll (TNP36-Ficoll; 
all from Biosearch Technologies) were alum precipitated by mixing them 
(1 mg/ml) with an aluminum hydroxide solution at a 1:1 ratio. Mice were 
immunized i.p. with 376 µg per 100 g body weight. After 6–7 d, serum was 
collected and the mice were killed, and single-cell suspensions of the spleen 
were used for the ELISPOT assay and analyzed by flow cytometry. Titers of 
antigen-specific antibodies were measured by ELISA. In brief, plates were 
coated with antigen (NP15-BSA or TNP13-BSA from Biosearch Technolo-
gies) for the capture of the serum antibodies, and goat anti–mouse HRPO-
conjugated antibodies were used for detection (IgM, IgG, IgG1, and IgG3; all 
from SouthernBiotech). Each serum sample was serially diluted and absor-
bance at 405 nm measured. Data were adjusted to best-fit sigmoidal curve 
and the EC50 calculated using GraphPad Prism software. For ELISPOT, 
spleen single-cell suspensions were incubated for 16 h in multiscreen filtra-
tion plates (EMD Millipore) previously coated with antigen (NP15-BSA or 
Peptides were analyzed by LC-MS/MS on a nanoscale-HPLC Agilent 
1200 (Agilent Technologies) connected online to an LTQ-Orbitrap XL 
mass spectrometer (Thermo Fisher Scientific). All full-scan acquisition was 
performed in the FT-MS part of the mass spectrometer in the range from 
m/z 350 to 2,000 with an automatic gain CTRL target value of 106 and at 
resolution 60,000 at m/z 400. MS/MS acquisition was performed on the 
five most intense ions of the full scan in the LTQ using the following param-
eters: AGC target value, 5,000; ion selection thresholds, 1,000 counts; and 
maximum fill time, 100 ms. Wide-band activation was enabled with an activa-
tion q = 0.25 applied for 30 ms at a normalized collision energy of 35%. Singly 
charged ions and ions with unassigned charge states were excluded from 
MS/MS. Dynamic exclusion was applied. All recorded LC-MS/MS raw 
files were processed together in MaxQuant (Cox and Mann, 2008). Database 
searches were performed with the following parameters: mass accuracy thresh-
olds were 0.5 D (MS/MS) and 6 ppm (precursor), maximum two missed 
cleavages were allowed, carbamidomethylation of cysteine as fixed modifica-
tion, and deamidation (N/Q), oxidation (M), phosphorylation (STY), and 
protein N-terminal acetylation were set as variable modifications. MaxQuant 
was used to filter the identifications for a false discovery rate below 1% for 
peptides and proteins using forward-decoy searching.
Flow cytometry. Lymphocytes were isolated from the organs and erythro-
cytes removed by incubation in erythrocyte lysis buffer, 150 mM NH4Cl and 
10 mM KHCO3, for 2–4 min at room temperature. 0.3 × 106 cells were 
stained on ice and in the dark for a minimum of 20 min in PBS containing 
1% FCS and the indicated antibodies. Before analysis, cells were washed a mini-
mum of two times. Measurements were performed using a Gallios (Beckham 
Coulter), Cyan (Beckham Coulter), or LSRII (BD) flow cytometer. Data 
were analyzed with FlowJo 6.1 software.
Antibodies. The following antibodies were used for WT: anti-Kidins220 
(Proteintech), anti–Ig- (Gold et al., 1991; provided by M. Gold, Univer-
sity of British Columbia, Vancouver, British Columbia, Canada), anti–Ig-, 
anti–p-PLC2, anti–c-Fos, anti–p-Akt, and anti-Actin (all from Santa Cruz 
Biotechnology, Inc.); anti–LC-HRPO and anti–LC-HRPO (both from 
SouthernBiotech); anti-GAPDH (Sigma-Aldrich); and anti-pRaf, anti–p-
Erk1/2, and anti–p-Mek antibodies (all from Cell Signaling Technology). 
Anti–Raf-1 (C12) and anti–B-Raf antibodies (H145 for IP, F7 for detection) 
were purchased from Santa Cruz Biotechnologies, Inc.
The following antibodies were used for flow cytometry: FITC-labeled 
anti-B220 and FITC-labeled anti-IgD (both from SouthernBiotech); PECy7-
labeled anti-B220, PE-labeled anti-IgM, PE-labeled anti-cKit, APC-labeled 
anti-CD5, biotin-labeled anti-CD21, FITC-labeled anti-CD19, PE-labeled 
anti-CD23, and PE-labeled anti-CD43 (all from eBioscience); DL649- 
labeled anti–IgM Fab2 (all from Jackson ImmunoResearch Laboratories, Inc.); 
PECy7-labeled anti-IgM, FITC-labeled anti-LC, APC-labeled anti-CD21, 
biotin-labeled anti-CD34, V450-labeled anti-CD45.2, FITC-labeled anti-
CD45.1, FITC-labeled anti-Gl7, PE-labeled anti-CD95, and anti-IgG1 (all 
from BD); and PB-labeled anti-CD19, PECy7-labeled anti-CD23, and APC-
labeled anti-CD93 (all from BioLegend). NP-BSA-biotin was obtained from 
Biosearch Technologies.
Cell stimulation and protein purifications. Cells were starved for 1 h 
and then stimulated for the indicated times at 37°C with 3 µg/ml anti-LC–
biotin (SouthernBiotech), 10 µg/ml anti-idiotypic Ac146 (Reth et al., 1978), 
or 3 µg/ml anti–mouse IgM Fab2 (Dianova) antibodies or with 25 µM per-
vanadate for 3 min. Treatment with the Src kinase inhibitor PP2 (Sigma-
Aldrich) was performed at a concentration of 20 µM for 30 min at 37°C before 
stimulation. For BCR purifications, cells were lysed at a maximum of 40 × 
106 cells/ml in 1 ml lysis buffer containing 0.5% Brij96V as described previ-
ously (Adachi et al., 1996), whereas RIPA buffer was used for lysate prepara-
tions. 40 µl was kept as a lysate CTRL. BCRs were purified from postnuclear 
supernatants by incubation with protein G–Sepharose or NP-coupled beads 
for 1–3 h at 4°C. MHCI was purified with the antibody SF1-1.1 (BD) and 
protein G–Sepharose. Raf immunoprecipitations were performed as described 
 o
n
 Septem
ber 2, 2015
jem.rupress.org
D
ow
nloaded from
 
Published August 31, 2015
 of 6 Kidins220 regulates B cell activation | Fiala et al.
Kidins220/ARMS mediates the integration of the neurotrophin and 
VEGF pathways in the vascular and nervous systems. Cell Death Differ. 
19:194–208. http://dx.doi.org/10.1038/cdd.2011.141
Chang, M.S., J.C. Arevalo, and M.V. Chao. 2004. Ternary complex with 
Trk, p75, and an ankyrin-rich membrane spanning protein. J. Neurosci. 
Res. 78:186–192. http://dx.doi.org/10.1002/jnr.20262
Cox, J., and M. Mann. 2008. MaxQuant enables high peptide identification 
rates, individualized p.p.b.-range mass accuracies and proteome-wide 
protein quantification. Nat. Biotechnol. 26:1367–1372. http://dx.doi.org/ 
10.1038/nbt.1511
Cumano, A., K. Dorshkind, S. Gillis, and C.J. Paige. 1990. The influence of S17 
stromal cells and interleukin 7 on B cell development. Eur. J. Immunol. 
20:2183–2189. http://dx.doi.org/10.1002/eji.1830201006
Derudder, E., E.J. Cadera, J.C. Vahl, J. Wang, C.J. Fox, S. Zha, G. van Loo, 
M. Pasparakis, M.S. Schlissel, M. Schmidt-Supprian, and K. Rajewsky. 
2009. Development of immunoglobulin -chain–positive B cells, but 
not editing of immunoglobulin -chain, depends on NF-B signals. Nat. 
Immunol. 10:647–654. http://dx.doi.org/10.1038/ni.1732
Deswal, S., A. Meyer, G.J. Fiala, A.E. Eisenhardt, L.C. Schmitt, M. Salek, T. 
Brummer, O. Acuto, and W.W. Schamel. 2013. Kidins220/ARMS associates 
with B-Raf and the TCR, promoting sustained Erk signaling in T cells. J. 
Immunol. 190:1927–1935. http://dx.doi.org/10.4049/jimmunol.1200653
Dhillon, A.S., S. Meikle, Z. Yazici, M. Eulitz, and W. Kolch. 2002. Regulation 
of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21: 
64–71. http://dx.doi.org/10.1093/emboj/21.1.64
Dingjan, G.M., S. Middendorp, K. Dahlenborg, A. Maas, F. Grosveld, and 
R.W. Hendriks. 2001. Bruton’s tyrosine kinase regulates the activation of 
gene rearrangements at the lambda light chain locus in precursor B cells 
in the mouse. J. Exp. Med. 193:1169–1178. http://dx.doi.org/10.1084/ 
jem.193.10.1169
Dougherty, M.K., J. Müller, D.A. Ritt, M. Zhou, X.Z. Zhou, T.D. Copeland, 
T.P. Conrads, T.D. Veenstra, K.P. Lu, and D.K. Morrison. 2005. Regulation 
of Raf-1 by direct feedback phosphorylation. Mol. Cell. 17:215–224. 
http://dx.doi.org/10.1016/j.molcel.2004.11.055
Engel, H., A. Rolink, and S. Weiss. 1999. B cells are programmed to activate 
 and  for rearrangement at consecutive developmental stages. Eur. J. 
Immunol. 29:2167–2176. http://dx.doi.org/10.1002/(SICI)1521-4141 
(199907)29:07<2167::AID-IMMU2167>3.0.CO;2-H
Fleming, H.E., and C.J. Paige. 2001. Pre-B cell receptor signaling mediates se-
lective response to IL-7 at the pro-B to pre-B cell transition via an ERK/
MAP kinase-dependent pathway. Immunity. 15:521–531. http://dx.doi 
.org/10.1016/S1074-7613(01)00216-3
Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an 
approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177: 
999–1008. http://dx.doi.org/10.1084/jem.177.4.999
Gerlach, J., S. Ghosh, H. Jumaa, M. Reth, J. Wienands, A.C. Chan, and L. 
Nitschke. 2003. B cell defects in SLP65/BLNK-deficient mice can be 
partially corrected by the absence of CD22, an inhibitory coreceptor 
for BCR signaling. Eur. J. Immunol. 33:3418–3426. http://dx.doi.org/10 
.1002/eji.200324290
Gold, M.R. 2000. Intermediary signaling effectors coupling the B-cell re-
ceptor to the nucleus. Curr. Top. Microbiol. Immunol. 245:77–134.
Gold, M.R., L. Matsuuchi, R.B. Kelly, and A.L. DeFranco. 1991. Tyrosine 
phosphorylation of components of the B-cell antigen receptors fol-
lowing receptor crosslinking. Proc. Natl. Acad. Sci. USA. 88:3436–3440. 
http://dx.doi.org/10.1073/pnas.88.8.3436
Grandien, A., R. Fucs, A. Nobrega, J. Andersson, and A. Coutinho. 1994. 
Negative selection of multireactive B cell clones in normal adult 
mice. Eur. J. Immunol. 24:1345–1352. http://dx.doi.org/10.1002/eji 
.1830240616
Gross, J.A., J. Johnston, S. Mudri, R. Enselman, S.R. Dillon, K. Madden, W. Xu, 
J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA 
are receptors for a TNF homologue implicated in B-cell autoimmune 
disease. Nature. 404:995–999. http://dx.doi.org/10.1038/35010115
Hanke, J.H., J.P. Gardner, R.L. Dow, P.S. Changelian, W.H. Brissette, E.J. 
Weringer, B.A. Pollok, and P.A. Connelly. 1996. Discovery of a novel, 
potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- 
and FynT-dependent T cell activation. J. Biol. Chem. 271:695–701. 
http://dx.doi.org/10.1074/jbc.271.2.695
TNP13-BSA). ASCs were detected by incubation with goat anti–mouse HRPO-
conjugated antibodies (IgM or IgG; from SouthernBiotech) and subsequently 
with 3-amino-9-ethyl-carbazole (Sigma-Aldrich). Spots were counted using 
an automated reader.
We appreciate the BIOSS toolbox for providing us with reagents. We thank C. Johner, 
U. Stauffer, N. Joswig, N. Knoll, J. Hülsdünker, K. Fehrenbach, E. Dengler, E. Levit,  
C. Schell, T. Huber, and S. Braun for experimental help; M. Gold for providing the 
anti-Ig antiserum; G. Schiavo for the Kidins220-deficient mice; F. Batista, A. Izcue, 
and S. Infantino for sharing procedures; and J. Wienands, L. Nitschke, P. Nielsen,  
S. Deswal, and R. Pelanda for discussions.
This work was supported by the German Research Foundation (DFG) through 
the Excellence Initiative GSC-4 (Spemann Graduate School of Biology and Medicine) 
and EXC294 (BIOSS) to G.J. Fiala, J. Dengjel, T. Brummer, M. Reth, and W.W.A. 
Schamel. T. Brummer was supported by the Emmy-Noether Program of the DFG.  
S. Minguet was supported by the DFG through SFB1160 and M. Reth by ERC grant 
32297 and by the DFG through SFB746 and TRR130.
The authors declare no competing financial interests.
Submitted: 3 July 2014
Accepted: 14 August 2015
REFERENCES
Adachi, T., W.W. Schamel, K.M. Kim, T. Watanabe, B. Becker, P.J. Nielsen, and 
M. Reth. 1996. The specificity of association of the IgD molecule with 
the accessory proteins BAP31/BAP29 lies in the IgD transmembrane 
sequence. EMBO J. 15:1534–1541.
Allman, D., R.C. Lindsley, W. DeMuth, K. Rudd, S.A. Shinton, and R.R. 
Hardy. 2001. Resolution of three nonproliferative immature splenic B cell 
subsets reveals multiple selection points during peripheral B cell matura-
tion. J. Immunol. 167:6834–6840. http://dx.doi.org/10.4049/jimmunol 
.167.12.6834
Arakawa, H., T. Shimizu, and S. Takeda. 1996. Re-evaluation of the prob-
abilities for productive arrangements on the  and  loci. Int. Immunol. 
8:91–99. http://dx.doi.org/10.1093/intimm/8.1.91
Arévalo, J.C., H. Yano, K.K. Teng, and M.V. Chao. 2004. A unique pathway for 
sustained neurotrophin signaling through an ankyrin-rich membrane-
spanning protein. EMBO J. 23:2358–2368. http://dx.doi.org/10.1038/ 
sj.emboj.7600253
Bai, L., Y. Chen, Y. He, X. Dai, X. Lin, R. Wen, and D. Wang. 2007. Phospholipase 
C2 contributes to light-chain gene activation and receptor editing. Mol. 
Cell. Biol. 27:5957–5967. http://dx.doi.org/10.1128/MCB.02273-06
Brummer, T., P.E. Shaw, M. Reth, and Y. Misawa. 2002. Inducible gene dele-
tion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor 
signalling. EMBO J. 21:5611–5622. http://dx.doi.org/10.1093/emboj/ 
cdf588
Brummer, T., H. Naegele, M. Reth, and Y. Misawa. 2003. Identification of novel 
ERK-mediated feedback phosphorylation sites at the C-terminus of B-
Raf. Oncogene. 22:8823–8834. http://dx.doi.org/10.1038/sj.onc.1207185
Campbell, K.S., W.D. Bedzyk, and J.C. Cambier. 1995. Manipulation of B cell 
antigen receptor tyrosine phosphorylation using aluminum fluoride and 
sodium orthovanadate. Mol. Immunol. 32:1283–1294. http://dx.doi.org/ 
10.1016/0161-5890(95)00088-7
Castellanos, M.C., C. Muñoz, M.C. Montoya, E. Lara-Pezzi, M. López-
Cabrera, and M.O. de Landázuri. 1997. Expression of the leukocyte early 
activation antigen CD69 is regulated by the transcription factor AP-1. 
J. Immunol. 159:5463–5473.
Castello, A., M. Gaya, J. Tucholski, T. Oellerich, K.H. Lu, A. Tafuri, T. Pawson, 
J. Wienands, M. Engelke, and F.D. Batista. 2013. Nck-mediated recruit-
ment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells. 
Nat. Immunol. 14:966–975. http://dx.doi.org/10.1038/ni.2685
Cesca, F., A. Yabe, B. Spencer-Dene, A. Arrigoni, M. Al-Qatari, D. Henderson, 
H. Phillips, M. Koltzenburg, F. Benfenati, and G. Schiavo. 2011. Kidins220/
ARMS is an essential modulator of cardiovascular and nervous sys-
tem development. Cell Death Dis. 2:e226. http://dx.doi.org/10.1038/ 
cddis.2011.108
Cesca, F., A. Yabe, B. Spencer-Dene, J. Scholz-Starke, L. Medrihan, C.H. 
Maden, H. Gerhardt, I.R. Orriss, P. Baldelli, M. Al-Qatari, et al. 2012. 
 o
n
 Septem
ber 2, 2015
jem.rupress.org
D
ow
nloaded from
 
Published August 31, 2015
JEM 
Article
 of 6
light-chain recombination during early B cell development. Nat. Immunol. 
10:1110–1117. http://dx.doi.org/10.1038/ni.1785
Martin, F., and J.F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 
2:323–335. http://dx.doi.org/10.1038/nri799
Mason, C.S., C.J. Springer, R.G. Cooper, G. Superti-Furga, C.J. Marshall, 
and R. Marais. 1999. Serine and tyrosine phosphorylations cooperate in 
Raf-1, but not B-Raf activation. EMBO J. 18:2137–2148. http://dx.doi 
.org/10.1093/emboj/18.8.2137
McGuire, K.L., and E.S. Vitetta. 1981. / Shifts do not occur during mat-
uration of murine B cells. J. Immunol. 127:1670–1673.
Minguet, S., M. Huber, L. Rosenkranz, W.W. Schamel, M. Reth, and T. 
Brummer. 2005. Adenosine and cAMP are potent inhibitors of the 
NF-B pathway downstream of immunoreceptors. Eur. J. Immunol. 35: 
31–41. http://dx.doi.org/10.1002/eji.200425524
Minguet, S., E.P. Dopfer, C. Pollmer, M.A. Freudenberg, C. Galanos, M. Reth, 
M. Huber, and W.W. Schamel. 2008. Enhanced B-cell activation medi-
ated by TLR4 and BCR crosstalk. Eur. J. Immunol. 38:2475–2487. http://
dx.doi.org/10.1002/eji.200738094
Nagaoka, H., Y. Takahashi, R. Hayashi, T. Nakamura, K. Ishii, J. Matsuda, A. 
Ogura, Y. Shirakata, H. Karasuyama, T. Sudo, et al. 2000. Ras mediates ef-
fector pathways responsible for pre-B cell survival, which is essential for 
the developmental progression to the late pre-B cell stage. J. Exp. Med. 
192:171–182. http://dx.doi.org/10.1084/jem.192.2.171
Nemazee, D. 2006. Receptor editing in lymphocyte development and central 
tolerance. Nat. Rev. Immunol. 6:728–740. http://dx.doi.org/10.1038/ 
nri1939
Neubrand, V.E., F. Cesca, F. Benfenati, and G. Schiavo. 2012. Kidins220/
ARMS as a functional mediator of multiple receptor signalling pathways. 
J. Cell Sci. 125:1845–1854. http://dx.doi.org/10.1242/jcs.102764
Oh-hora, M., S. Johmura, A. Hashimoto, M. Hikida, and T. Kurosaki. 2003. 
Requirement for Ras guanine nucleotide releasing protein 3 in coupling 
phospholipase C-2 to Ras in B cell receptor signaling. J. Exp. Med. 
198:1841–1851. http://dx.doi.org/10.1084/jem.20031547
Oi, V.T., S.L. Morrison, L.A. Herzenberg, and P. Berg. 1983. Immunoglobulin 
gene expression in transformed lymphoid cells. Proc. Natl. Acad. Sci. USA. 
80:825–829. http://dx.doi.org/10.1073/pnas.80.3.825
Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lympho-
cyte cell fate decision. Nat. Rev. Immunol. 9:767–777. http://dx.doi.org/ 
10.1038/nri2656
Ray, R.J., A. Stoddart, J.L. Pennycook, H.O. Huner, C. Furlonger, G.E. Wu, 
and C.J. Paige. 1998. Stromal cell-independent maturation of IL-7-
responsive pro-B cells. J. Immunol. 160:5886–5897.
Reth, M., G.J. Hämmerling, and K. Rajewsky. 1978. Analysis of the reper-
toire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characteri-
zation of antibody families in the primary and hyperimmune response. 
Eur. J. Immunol. 8:393–400. http://dx.doi.org/10.1002/eji.1830080605
Richards, J.D., S.H. Davé, C.H. Chou, A.A. Mamchak, and A.L. DeFranco. 
2001. Inhibition of the MEK/ERK signaling pathway blocks a subset 
of B cell responses to antigen. J. Immunol. 166:3855–3864. http://dx.doi 
.org/10.4049/jimmunol.166.6.3855
Rodriguez-Viciana, P., J. Oses-Prieto, A. Burlingame, M. Fried, and F. McCormick. 
2006. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the cata-
lytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. 
Mol. Cell. 22:217–230. http://dx.doi.org/10.1016/j.molcel.2006.03.027
Rolink, A., and F. Melchers. 1991. Molecular and cellular origins of B lym-
phocyte diversity. Cell. 66:1081–1094. http://dx.doi.org/10.1016/0092- 
8674(91)90032-T
Rolink, A., A. Kudo, H. Karasuyama, Y. Kikuchi, and F. Melchers. 1991. Long-
term proliferating early pre B cell lines and clones with the potential to 
develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. 
EMBO J. 10:327–336.
Rolli, V., M. Gallwitz, T. Wossning, A. Flemming, W.W. Schamel, C. Zürn, and 
M. Reth. 2002. Amplification of B cell antigen receptor signaling by 
a Syk/ITAM positive feedback loop. Mol. Cell. 10:1057–1069. http://
dx.doi.org/10.1016/S1097-2765(02)00739-6
Rowland, S.L., C.L. DePersis, R.M. Torres, and R. Pelanda. 2010a. Ras 
activation of Erk restores impaired tonic BCR signaling and rescues im-
mature B cell differentiation. J. Exp. Med. 207:607–621. http://dx.doi 
.org/10.1084/jem.20091673
Hashimoto, A., H. Okada, A. Jiang, M. Kurosaki, S. Greenberg, E.A. Clark, 
and T. Kurosaki. 1998. Involvement of guanosine triphosphatases and 
phospholipase C-2 in extracellular signal-regulated kinase, c-Jun NH2- 
terminal kinase, and p38 mitogen-activated protein kinase activation by 
the B cell antigen receptor. J. Exp. Med. 188:1287–1295. http://dx.doi 
.org/10.1084/jem.188.7.1287
Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P.J. Nielsen, R. Pelanda, and 
M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-
cre mice. Proc. Natl. Acad. Sci. USA. 103:13789–13794. http://dx.doi 
.org/10.1073/pnas.0605944103
Hombach, J., L. Leclercq, A. Radbruch, K. Rajewsky, and M. Reth. 1988. A 
novel 34-kd protein co-isolated with the IgM molecule in surface IgM-
expressing cells. EMBO J. 7:3451–3456.
Hombach, J., T. Tsubata, L. Leclercq, H. Stappert, and M. Reth. 1990. Molecular 
components of the B-cell antigen receptor complex of the IgM class. 
Nature. 343:760–762. http://dx.doi.org/10.1038/343760a0
Iglesias, T., N. Cabrera-Poch, M.P. Mitchell, T.J. Naven, E. Rozengurt, and G. 
Schiavo. 2000. Identification and cloning of Kidins220, a novel neuronal 
substrate of protein kinase D. J. Biol. Chem. 275:40048–40056. http://
dx.doi.org/10.1074/jbc.M005261200
Jean-Mairet, R.M., C. López-Menéndez, L. Sánchez-Ruiloba, S. Sacristán, 
M. Rodríguez-Martínez, L. Riol-Blanco, P. Sánchez-Mateos, F. Sánchez-
Madrid, J.L. Rodríguez-Fernández, M.R. Campanero, and T. Iglesias. 
2011. The neuronal protein Kidins220/ARMS associates with ICAM-
3 and other uropod components and regulates T-cell motility. Eur. J. 
Immunol. 41:1035–1046. http://dx.doi.org/10.1002/eji.201040513
Jumaa, H., B. Wollscheid, M. Mitterer, J. Wienands, M. Reth, and P.J. Nielsen. 
1999. Abnormal development and function of B lymphocytes in mice 
deficient for the signaling adaptor protein SLP-65. Immunity. 11:547–
554. http://dx.doi.org/10.1016/S1074-7613(00)80130-2
Justement, L.B., J. Wienands, J. Hombach, M. Reth, and J.C. Cambier. 1990. 
Membrane IgM and IgD molecules fail to transduce Ca2+ mobilizing 
signals when expressed on differentiated B lineage cells. J. Immunol. 144: 
3272–3280.
Kim, K.J., C. Kanellopoulos-Langevin, R.M. Merwin, D.H. Sachs, and R. 
Asofsky. 1979. Establishment and characterization of BALB/c lymphoma 
lines with B cell properties. J. Immunol. 122:549–554.
Kong, H., J. Boulter, J.L. Weber, C. Lai, and M.V. Chao. 2001. An evolution-
arily conserved transmembrane protein that is a novel downstream target 
of neurotrophin and ephrin receptors. J. Neurosci. 21:176–185.
Koretzky, G.A., F. Abtahian, and M.A. Silverman. 2006. SLP76 and SLP65: 
complex regulation of signalling in lymphocytes and beyond. Nat. Rev. 
Immunol. 6:67–78. http://dx.doi.org/10.1038/nri1750
Kraus, M., M.B. Alimzhanov, N. Rajewsky, and K. Rajewsky. 2004. Survival 
of resting mature B lymphocytes depends on BCR signaling via the 
Ig/ heterodimer. Cell. 117:787–800. http://dx.doi.org/10.1016/j.cell 
.2004.05.014
Kurosaki, T. 1999. Genetic analysis of B cell antigen receptor signaling. Annu. 
Rev. Immunol. 17:555–592. http://dx.doi.org/10.1146/annurev.immunol 
.17.1.555
Lam, K.P., R. Kühn, and K. Rajewsky. 1997. In vivo ablation of surface 
immunoglobulin on mature B cells by inducible gene targeting results in 
rapid cell death. Cell. 90:1073–1083. http://dx.doi.org/10.1016/S0092- 
8674(00)80373-6
Loder, F., B. Mutschler, R.J. Ray, C.J. Paige, P. Sideras, R. Torres, M.C. Lamers, 
and R. Carsetti. 1999. B cell development in the spleen takes place in dis-
crete steps and is determined by the quality of B cell receptor-derived sig-
nals. J. Exp. Med. 190:75–89. http://dx.doi.org/10.1084/jem.190.1.75
López-Menéndez, C., S. Gascón, M. Sobrado, O.G. Vidaurre, A.M. Higuero, 
A. Rodríguez-Peña, T. Iglesias, and M. Díaz-Guerra. 2009. Kidins220/
ARMS downregulation by excitotoxic activation of NMDARs reveals 
its involvement in neuronal survival and death pathways. J. Cell Sci. 
122:3554–3565. http://dx.doi.org/10.1242/jcs.056473
Mackay, F., S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, 
J. Tschopp, and J.L. Browning. 1999. Mice transgenic for BAFF develop 
lymphocytic disorders along with autoimmune manifestations. J. Exp. 
Med. 190:1697–1710. http://dx.doi.org/10.1084/jem.190.11.1697
Mandal, M., S.E. Powers, K. Ochiai, K. Georgopoulos, B.L. Kee, H. Singh, 
and M.R. Clark. 2009. Ras orchestrates exit from the cell cycle and 
 o
n
 Septem
ber 2, 2015
jem.rupress.org
D
ow
nloaded from
 
Published August 31, 2015
6 of 6 Kidins220 regulates B cell activation | Fiala et al.
Rowland, S.L., K.F. Leahy, R. Halverson, R.M. Torres, and R. Pelanda. 2010b. 
BAFF receptor signaling aids the differentiation of immature B cells into 
transitional B cells following tonic BCR signaling. J. Immunol. 185:4570–
4581. http://dx.doi.org/10.4049/jimmunol.1001708
Schamel, W.W., and M. Reth. 2000. Monomeric and oligomeric complexes 
of the B cell antigen receptor. Immunity. 13:5–14. http://dx.doi.org/ 
10.1016/S1074-7613(00)00003-0
Shaw, A.C., W. Swat, R. Ferrini, L. Davidson, and F.W. Alt. 1999. Activated 
Ras signals developmental progression of recombinase-activating gene 
(RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189:123–129.
Sidorenko, S.P., C.L. Law, S.J. Klaus, K.A. Chandran, M. Takata, T. Kurosaki, and 
E.A. Clark. 1996. Protein kinase C  (PKC) associates with the B cell 
antigen receptor complex and regulates lymphocyte signaling. Immunity. 
5:353–363. http://dx.doi.org/10.1016/S1074-7613(00)80261-7
Sonoda, E., Y. Pewzner-Jung, S. Schwers, S. Taki, S. Jung, D. Eilat, and K. Rajewsky. 
1997. B cell development under the condition of allelic inclusion. Immunity. 
6:225–233. http://dx.doi.org/10.1016/S1074-7613(00)80325-8
Sprenger, A., S. Weber, M. Zarai, R. Engelke, J.M. Nascimento, C. Gretzmeier, 
M. Hilpert, M. Boerries, C. Has, H. Busch, et al. 2013. Consistency of the 
proteome in primary human keratinocytes with respect to gender, age, 
and skin localization. Mol. Cell. Proteomics. 12:2509–2521. http://dx.doi 
.org/10.1074/mcp.M112.025478
Srivastava, B., W.J. Quinn III, K. Hazard, J. Erikson, and D. Allman. 2005. 
Characterization of marginal zone B cell precursors. J. Exp. Med. 202: 
1225–1234. http://dx.doi.org/10.1084/jem.20051038
Sugawara, H., M. Kurosaki, M. Takata, and T. Kurosaki. 1997. Genetic evidence 
for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate re-
ceptors in signal transduction through the B-cell antigen receptor. EMBO 
J. 16:3078–3088. http://dx.doi.org/10.1093/emboj/16.11.3078
Takeda, S., Y.R. Zou, H. Bluethmann, D. Kitamura, U. Muller, and K. Rajewsky. 
1993. Deletion of the immunoglobulin kappa chain intron enhancer 
abolishes kappa chain gene rearrangement in cis but not lambda chain 
gene rearrangement in trans. EMBO J. 12:2329–2336.
ten Boekel, E., F. Melchers, and A. Rolink. 1995. The status of Ig loci rear-
rangements in single cells from different stages of B cell development. Int. 
Immunol. 7:1013–1019. http://dx.doi.org/10.1093/intimm/7.6.1013
Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-
reactive bone marrow B cells. J. Exp. Med. 177:1009–1020. http://dx.doi 
.org/10.1084/jem.177.4.1009
Vettermann, C., K. Herrmann, C. Albert, E. Roth, M.R. Bösl, and H.M. 
Jäck. 2008. A unique role for the 5 nonimmunoglobulin tail in early 
B lymphocyte development. J. Immunol. 181:3232–3242. http://dx.doi 
.org/10.4049/jimmunol.181.5.3232
Wheeler, M.L., M.B. Dong, R. Brink, X.P. Zhong, and A.L. DeFranco. 2013. 
Diacylglycerol kinase  limits B cell antigen receptor-dependent activa-
tion of ERK signaling to inhibit early antibody responses. Sci. Signal. 
6:ra91. http://dx.doi.org/10.1126/scisignal.2004189
Wienands, J., O. Larbolette, and M. Reth. 1996. Evidence for a preformed 
transducer complex organized by the B cell antigen receptor. Proc. Natl. 
Acad. Sci. USA. 93:7865–7870. http://dx.doi.org/10.1073/pnas.93 
.15.7865
Wienands, J., J. Schweikert, B. Wollscheid, H. Jumaa, P.J. Nielsen, and M. Reth. 
1998. SLP-65: a new signaling component in B lymphocytes which re-
quires expression of the antigen receptor for phosphorylation. J. Exp. 
Med. 188:791–795.
Yang, J., and M. Reth. 2010. Oligomeric organization of the B-cell anti-
gen receptor on resting cells. Nature. 467:465–469. http://dx.doi.org/10 
.1038/nature09357
Yasuda, T., H. Sanjo, G. Pagès, Y. Kawano, H. Karasuyama, J. Pouysségur, M. 
Ogata, and T. Kurosaki. 2008. Erk kinases link pre-B cell receptor signal-
ing to transcriptional events required for early B cell expansion. Immunity. 
28:499–508. http://dx.doi.org/10.1016/j.immuni.2008.02.015
 o
n
 Septem
ber 2, 2015
jem.rupress.org
D
ow
nloaded from
 
Published August 31, 2015
